Supplementary table 1.docx: A Phase I trial of talazoparib in patients witha dvanced hematologic malignancies
收藏DataCite Commons2024-05-17 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Supplementary_table_1_docx_A_Phase_I_trial_of_talazoparib_in_patients_witha_dvanced_hematologic_malignancies/16863334
下载链接
链接失效反馈官方服务：
资源简介：
<b>Supplementary Figure 1. </b>Dose linearity and
proportionality in plasma following multiple doses of talazoparib.<b> <br>
</b><b>Supplementary
material. </b>Medical
history of the patient in Cohort 1 who experienced possible drug-related
Grade 5 neutropenic sepsis.
<b>Supplementary Table 1. </b>Patient disposition by
dose level and diagnosis (safety population).<sup>†</sup><b></b>
<b>Supplementary Table 2. </b>Exposure to talazoparib
(safety population). <b></b>
提供机构：
Taylor & Francis
创建时间：
2021-10-23
